Search QAs

As per instructions log for S.08.01, S.08.02 & S.11.01 QRTs it is given that "On the table Information on derivative, each derivative shall be reported separately, with one line for each derivative, filling in all variables requested in that table."Q1. Does this mean that duplicates are allowed...

Our understanding of the items to be considered for reporting for closed derivatives are as follows:1. Derivatives that were open in the previous reporting period and got closed within the current reporting period2. Derivatives that were purchased and sold within the current reporting period...

Guarantees involving multiple group entitiesWe have read the EIOPA clarification issued on 20/05/2016 with regards to reporting of guarantees in these templates in the context of group reporting. We would like to seek further clarification on this matter. We would like to explain our question with...

Cash CollateralFor our derivative contracts we provide/receive collateral in the form of cash, securities or both. In line with IFRS cash collateral is recorded as an asset in the balance sheet (with a corresponding liability). Cash collaterals held:Although this template is called ‘Off-balance...

S.14.01For columns C0010 to C0080, how many rows should we have. Our interpretation is that there should be one row for each Product ID code. However, this should be split into multiple rows if the business is written from multiple countries as per column C0080. a) Is this interpretation correct?b...

S.14.01C0080We interpret the guidance to state that for each product code, if greater than 10% of TP or written premiums is written in a particular country, then that country has its own row. If less than 10% of TP or written premiums is written in a particular country, it can be combined with...

According to article 10 (b), (e) and (f) of Commission implementing regulation (EU) 2015/2450 of 2 December 2015 laying down implementing technical standards with regard to the templates for the submission of information to the supervisory authorities according to Directive 2009/138/EC of the...

The requirement says "The sum of provisions in templates S.16.01 and S.19.01 for one non-life line of business, as defined in Annex I to Delegated Regulation (EU) 2015/35, represents the total claims reserves originating from this line of business". Does it mean that "C0360/R0260", "C0960/R0460"...

We still struggle with the valuation method we should use on CIC 7 (and the subcatagory within). In one of the first CIC tables there was an explicit note that "XT" should be used for CIC 7, 8 and 9. Unfortunately in the latest version(s) there isn't such a note. Is the former note still in force...